Startups
Telesis Bio is a company that provides synthetic DNA/gene synthesis hardware, including the BioXp, which is the world’s first DNA printer. They are focused on enabling researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA. You can find more information about their products on their website.
Overview
Location
United States, California, San Diego
Employees
51-200
Phone
+1 855-474-4362
Founded date
2013
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 19, 2025 | Telesis Bio: $21 Million Raised For Accelerating Adoption Of Gibson SOLA Technology | Telesis Bio, a provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, announced that it has entered into a convertible preferred stock purchase agreement to sell ... |
| May 31, 2023 | Telesis Bio Secures Financing of $28.0 Million | |
| Apr 11, 2023 | This Desktop Machine Is About To Transform The Decades-Old DNA Synthesis Industry | Thomas Ybert, CEO of DNA Script.Thomas Ybert |
| Feb 20, 2023 | Telesis Bio Releases BioXp Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation | Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA Telesis Bio, a leader in automated multi-omic and synthetic biology solutions, announced the availability of its BioXp Select mRNA Synthesis Kit. Thi... |
Reviews 0
FAQ about Telesis Bio
When was Telesis Bio founded?
Telesis Bio was founded in 2013.
What has the press written about Telesis Bio?
Parsers VC has collected 5 articles mentioning Telesis Bio, among them “Telesis Bio: $21 Million Raised For Accelerating Adoption Of Gibson SOLA Technology” (Mar 19, 2025) and “Telesis Bio Secures Financing of $28.0 Million” (May 31, 2023).
Is Telesis Bio still active?
Yes, Telesis Bio is active; its latest activity on Parsers VC dates from Mar 19, 2025.